❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ Kjersti Flatmark's group ❭
Scroll to top

Home Dept. of Tumor Biology Kjersti Flatmark's group

  • Group members
  • From bench to bedside
  • Interventional clinical trials
  • Target discovery in peritoneal surface malignancies
  • Locally advanced and recurrent rectal cancer
  • Experimental treatment
  • Publications
  • News
  • Major collaborators

Recent publications

Høye E, Kanduri C, Torgunrud A, Lorenz S, Edwin B, Larsen SG, Fretland ÅA, Dagenborg VJ, Flatmark K, Lund-Andersen C (2025)
Enrichment of Cancer-Associated Fibroblasts, Macrophages, and Up-Regulated TNF-α Signaling in the Tumor Microenvironment of CMS4 Colorectal Peritoneal Metastasis
Cancer Med, 14 (1), e70521
DOI 10.1002/cam4.70521, PubMed 39739693

Wiig JN, Dagenborg VJ, Larsen SG (2024)
Ten-year survival and pattern of recurrence in patients with locally recurrent rectal or sigmoid cancer undergoing resection
Colorectal Dis, 27 (1) (in press)
DOI 10.1111/codi.17226, PubMed 39635974

Patrick-Brown TDJH, Barratt-Due A, Trøseid M, Dyrhol-Riise AM, Nezvalova-Henriksen K, Kåsine T, Aukrust P, Olsen IC, NOR Solidarity consortium (2024)
The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis
Commun Med (Lond), 4 (1), 231
DOI 10.1038/s43856-024-00650-4, PubMed 39533001



More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)